Nebido — Testosterone Undecanoate 1000 mg / 4 ml, 1 pcs, Grünenthal

Nebido — Testosterone Undecanoate 1000 mg/4 ml, 1 Vial

Product code: 485

7650₴ 7964₴ -4% On order · from 7 days

Analogues

Nebido Testoheal
1
Active ingredient
Dosage
1000 mg / 4 ml
Dosage form Solution for intramuscular injection
Units per pack 1
Packaging Vial in box

Nebido is an original long-acting hormonal formulation designed for testosterone replacement therapy (TRT) in adult men suffering from testosterone deficiency. The active pharmaceutical ingredient is testosterone undecanoate at a concentration of 250 mg/ml. The product is supplied as an oily solution for intramuscular injection in a 4 ml vial/ampoule, delivering a total dose of 1000 mg of testosterone undecanoate. The product is manufactured by the globally renowned pharmaceutical corporation Grünenthal under license and standards of Bayer.

The pharmacological hallmark of Nebido is its purified castor oil and benzyl benzoate vehicle, which ensures extremely slow and sustained release of active testosterone from the intramuscular depot. Following injection, the testosterone ester is gradually cleaved by natural serum esterases into free testosterone. Due to this advanced technology, stable physiological hormone levels are maintained for 10 to 14 weeks, freeing the patient from the burden of frequent weekly or bi-weekly injections associated with short-acting esters (such as enanthate or propionate).

Supplied in an outer carton containing 1 glass vial or ampoule of 4 ml. Administration must be performed strictly deep intramuscularly by a qualified healthcare professional using slow injection technique.

Key Clinical Features and Advantages of Nebido 1000 mg/4 ml:

  • ✅ Extended Longevity: Infrequent administration schedule (only 4 times a year after the loading phase) ensures maximum patient compliance and convenience.
  • ✅ Physiological Stability: Absence of sharp peak-and-valley hormone fluctuations common with short-acting testosterone esters.
  • ✅ Original Bayer / Grünenthal Quality: Stringent European quality control standards ensuring raw material purity and predictable pharmacokinetics.
  • ✅ Comprehensive Rejuvenation: Effectively alleviates clinical hypogonadism symptoms (reduced libido, fatigue, depressive moods, loss of muscle mass and bone density).
  • ✅ Safe Oily Carrier: Purified castor oil provides excellent biocompatibility and minimal local irritation when injected correctly.

Nebido is supplied as an oily solution for intramuscular injection.

Qualitative and Quantitative Composition (per 1 ml and per vial):

  • Active Ingredient: Testosterone undecanoate — 250 mg per 1 ml (totaling 1000 mg per 4 ml vial).
  • Excipients: Benzyl benzoate (solubilizer), purified castor oil (up to 1 ml).

Packaging and Presentation: Clear, yellowish to yellow oily solution. 4 ml solution in a colorless glass vial (or ampoule). 1 vial with official prescribing information per outer carton displaying Nebido (Testosterone Undecanoate 1000 mg/4 ml) alongside Grünenthal / Bayer corporate graphics.

Pharmacodynamics:
Testosterone is the principal natural androgen in men, responsible for the normal development of reproductive organs, secondary sex characteristics, libido, erectile function, erythropoiesis, muscle tissue growth, bone mineralization, and psychological well-being. In men with primary or secondary hypogonadism, exogenous administration of Nebido compensates for endogenous testosterone deficiency, resulting in clinically significant improvements in androgen-dependent parameters.

Pharmacokinetics:

  • Absorption: Following IM injection, the oily undecanoate solution forms a muscle depot from which testosterone is released extremely slowly into systemic circulation. Ester cleavage is mediated by serum esterases, yielding free testosterone.
  • Distribution: Approximately 98% of circulating testosterone binds to plasma proteins (sex hormone-binding globulin — SHBG, and albumin).
  • Metabolism: Metabolized primarily in the liver into active metabolites (dihydrotestosterone — DHT, and estradiol) as well as inactive 17-ketosteroids.
  • Elimination: Approximately 90% of the dose is excreted renally as glucuronic and sulfuric acid conjugates, with about 6% excreted fecally unchanged. The terminal half-life (T1/2) is dictated by release kinetics from the muscular depot and averages approximately 90 days.

Nebido is indicated for testosterone replacement therapy in adult men for primary and secondary hypogonadism:

  • Primary Hypogonadism (Hypergonadotropic): Congenital or acquired testicular failure (Klinefelter syndrome, castration, orchitis, chemotherapy or toxic testicular damage) associated with testosterone deficiency and infertility.
  • Secondary Hypogonadism (Hypogonadotropic): Hypothalamic-pituitary axis deficiency (hypopituitarism, Kallmann syndrome, pituitary tumors) resulting in reduced gonadotropin secretion and testosterone deficiency.

Nebido must be injected strictly deep intramuscularly (slowly over at least 2 minutes, ensuring aspiration is performed to prevent intravascular injection!). Must be administered by a healthcare professional.

Dosing Regimen & Treatment Schedule:

  • Loading Phase: The contents of 1 vial (1000 mg testosterone undecanoate) are injected at week 0. The second injection of 1000 mg is administered strictly 6 weeks after the initial injection to rapidly establish stable therapeutic hormone levels.
  • Maintenance Phase: Subsequent injections of 1000 mg are administered at intervals of 10 to 14 weeks.
  • Therapy Monitoring: Serum testosterone levels must be measured just prior to the next scheduled injection (at the end of the dosing interval) to ensure target trough concentrations are maintained.

Administration of Nebido is strictly contraindicated in:

  • Androgen-Dependent Tumors: Known or suspected carcinoma of the prostate or male breast.
  • Hepatic Neoplasms: Current or past history of liver tumors.
  • Hypersensitivity: Known hypersensitivity to testosterone undecanoate or any excipient (including castor oil).
  • Female Gender: Strictly contraindicated in women.
  • Pediatric Population: Safety and efficacy in boys under 18 years have not been established.

Evaluated drug interactions with exogenous testosterone include:

  • Oral Anticoagulants (Coumarin derivatives, warfarin): Androgens may enhance anticoagulant activity, increasing bleeding risks. Anticoagulant dose adjustment may be required.
  • Hepatic Enzyme Inducers/Inhibitors (barbiturates, rifampicin, carbamazepine): May alter androgen metabolism, lowering or elevating serum testosterone concentrations.
  • Antidiabetic Agents (insulin, oral hypoglycemics): Androgens may improve glucose tolerance and decrease insulin requirements.

Nebido is intended strictly for use in men. Use in pregnant or breastfeeding women is strictly contraindicated due to pronounced virilizing effects of androgens on the fetus.

The most frequent and clinically significant adverse reactions associated with testosterone therapy include:

  • Injection Site Reactions: Pain, discomfort, hematoma, pruritus, or inflammation at the injection site.
  • Hematologic System: Polycythemia (elevated hematocrit, erythrocyte count, and hemoglobin levels), requiring routine blood monitoring.
  • Skin & Appendages: Acne, seborrhea, accelerated hair loss (alopecia).
  • Metabolism & Nutrition: Weight gain, sodium and water retention, edema, dyslipidemia.
  • Endocrine System: Gynecomastia, suppression of spermatogenesis (azoospermia), reduction in testicular size with chronic use.
  • Psychiatric & Nervous System: Enhanced libido, mood alterations, anxiety, headache.
  • Prostate: Elevated prostate-specific antigen (PSA), risk of detecting or progressing subclinical prostate cancer (annual screening required).

Symptoms:
Acute overdose of oily testosterone undecanoate is unlikely due to the depot formulation. Overdose or excessively frequent dosing manifests as hypervirilization symptoms, severe polycythemia, irritability, and weight gain.

Treatment:
No specific antidote exists. Management involves temporary discontinuation of therapy until blood parameters normalize and hyperandrogenic symptoms subside.

Storage Requirements for Nebido:

  • 🌡️ Temperature Range: Store in original packaging protected from light at temperatures below 30 °C. Do not freeze!
  • 👶 Safety Precautions: Keep out of reach of children.
  • ⏳ Shelf Life: Stated on outer carton and ampoule/vial. Do not use past expiration date. Prescription-only medicine.

To verify authenticity of genuine Nebido (1000 mg / 4 ml) manufactured by Grünenthal / Bayer, inspect the following features:

  • ✅ Corporate Logos: Distinctive Bayer and/or Grünenthal corporate logo printed on the outer carton and vial/ampoule.
  • ✅ Packaging Markings: Laser-printed or embossed Batch No., manufacturing date, and expiration date matching across carton and ampoule.
  • ✅ Glass Quality: High-grade colorless glass with clean snap-off or rubber-stoppered crimped cap, featuring flawless labeling.
  • ✅ Prescribing Information: Includes an official multi-language or localized product leaflet inside the carton.
On order · from 7 days
100% original product
Delivery across Ukraine
1

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 12.11.2026

Customer reviews

No reviews yet

Your review can be the first!

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00